Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes

被引:9
|
作者
Wang, Banglu [1 ]
Cheng, Daoan [1 ]
Ma, Danyu [1 ]
Chen, Rui [1 ]
Li, Dong [1 ]
Zhao, Weiqing [1 ]
Fang, Cheng [1 ]
Ji, Mei [1 ]
机构
[1] Soochow Univ, Dept Oncol, Affiliated Hosp 3, 185 Juqian St, Changzhou 213003, Peoples R China
基金
中国博士后科学基金;
关键词
Exosome; PD-L1; Tumor-associated macrophages; Immunosuppression; PRE-METASTATIC NICHE; COMMUNICATION; EXPRESSION; PATHWAY;
D O I
10.1186/s12964-024-01473-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor cells primarily employ the PD-1/PD-L1 pathway to thwart the anti-tumor capabilities of T lymphocytes, inducing immunosuppression. This occurs through the direct interaction of PD-L1 with PD-1 on T lymphocyte surfaces. Recent research focusing on the tumor microenvironment has illuminated the pivotal role of immune cells, particularly tumor-associated macrophages (TAMs), in facilitating PD-L1-mediated immunosuppression. Exosomes, characterized by their ability to convey information and be engulfed by cells, significantly contribute to promoting TAM involvement in establishing PD-L1-mediated immunosuppression within the tumor microenvironment. Exosomes, characterized by their ability to convey information and be engulfed by cells, significantly contribute to promoting TAM involvement in establishing PD-L1-mediated immunosuppression within the tumor microenvironment. In addition to receiving signals from tumor-derived exosomes that promote PD-L1 expression, TAMs also exert control over PD-L1 expression in tumor cells through the release of exosomes. This paper aims to summarize the mechanisms by which exosomes participate in this process, identify crucial factors that influence these mechanisms, and explore innovative strategies for inhibiting or reversing the tumor-promoting effects of TAMs by targeting exosomes.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes
    Banglu Wang
    Daoan Cheng
    Danyu Ma
    Rui Chen
    Dong Li
    Weiqing Zhao
    Cheng Fang
    Mei Ji
    Cell Communication and Signaling, 22
  • [2] Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
    Pu, Yunzhou
    Ji, Qing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
    Lu, Di
    Ni, Zhen
    Liu, Xiguang
    Feng, Siyang
    Dong, Xiaoying
    Shi, Xiaoshun
    Zhai, Jianxue
    Mai, Shijie
    Jiang, Jianjun
    Wang, Zhizhi
    Wu, Hua
    Cai, Kaican
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [4] Assessing Expression of PD-L1 in Tumor-Associated Macrophages
    Zhang, Jia
    Fu, Junke
    Zhang, Guangjian
    JAMA ONCOLOGY, 2020, 6 (10) : 1634 - 1635
  • [5] Cytokine regulation of PD-L1 expression on tumor-associated myeloid cells
    Hartley, Genevieve
    Regan, Dan
    Guth, Amanda
    Dow, Steven
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [6] Role of tumor-associated macrophages in esophageal cancer: PD-L1 expression and prognosis
    Yagi, Taisuke
    Baba, Yoshifumi
    Koga, Yuki
    Uchihara, Tomoyuki
    Kiyozumi, Yuki
    Sawayama, Hiroshi
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    CANCER RESEARCH, 2018, 78 (13)
  • [7] PD-L1 and tumor-associated macrophages in de novo DLBCL
    McCord, Ronald
    Bolen, Christopher R.
    Koeppen, Hartmut
    Kadel, Edward E., III
    Oestergaard, Mikkel Z.
    Nielsen, Tina
    Sehn, Laurie H.
    Venstrom, Jeffrey M.
    BLOOD ADVANCES, 2019, 3 (04) : 531 - 540
  • [8] Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
    Li, Wei
    Wu, Fenglei
    Zhao, Shaolin
    Shi, Peiqin
    Wang, Shengjun
    Cui, Dawei
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 67 : 49 - 57
  • [9] Tumor-associated macrophages infiltration highly associated with PD-L1 expression in gastric cancer
    Harada, Kazuto
    Estrella, Jeannelyn S.
    Correa, Arlene M.
    Ma, Lang
    Dong, Xiaoquan
    Xu, Yan
    Hofstette, Wayne L.
    Sudo, Kazuki
    Onodera, Hisashi
    Suzuki, Koyu
    Suzuki, Akihiro
    Johnson, Randy L.
    Zhenning, Zhenning
    Song, Shumei
    Ajani, Jaffer A.
    Onodera, Hisashi
    CANCER RESEARCH, 2017, 77
  • [10] Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
    Hua-Zhen Xu
    Tong-Fei Li
    Chao Wang
    Yan Ma
    Yan Liu
    Mei-Yan Zheng
    Zhang-Jun-Yan Liu
    Jin-Bo Chen
    Ke Li
    Shi-Kuan Sun
    Naoki Komatsu
    Yong-Hong Xu
    Li Zhao
    Xiao Chen
    Journal of Nanobiotechnology, 19